Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 93

1.

Elimination of different leukaemia subtypes using novel CD89-specific human cytolytic fusion proteins.

Gresch G, Schenke L, Mladenov R, Zwirner S, Cremer C, Niesen J, Grieger E, Brümmendorf T, Jost E, Fischer R, Stockmeyer B, Barth S, Nachreiner T, Stein C.

Br J Haematol. 2017 Oct 19. doi: 10.1111/bjh.14971. [Epub ahead of print] No abstract available.

PMID:
29048126
2.

Circulating CD89-IgA complex does not predict deterioration of kidney function in Korean patients with IgA nephropathy.

Jhee JH, Kang HY, Wu M, Nam BY, Chang TI, Jung SY, Park S, Kim H, Yun HR, Kee YK, Yoon CY, Park JT, Yoo TH, Kang SW, Han SH.

Clin Chem Lab Med. 2017 Nov 27;56(1):75-85. doi: 10.1515/cclm-2017-0090.

PMID:
28672768
3.

Discovery of a novel splice variant of Fcar (CD89) unravels sequence segments necessary for efficient secretion: A story of bad signal peptides and good ones that nevertheless do not make it.

Lua WH, Ling WL, Su CT, Yeo JY, Verma CS, Eisenhaber B, Eisenhaber F, Gan SK.

Cell Cycle. 2017 Mar 4;16(5):457-467. doi: 10.1080/15384101.2017.1281480. Epub 2017 Jan 19.

4.

Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.

Xu L, Li B, Huang M, Xie K, Li D, Li Y, Gu H, Fang J.

PLoS One. 2016 Jul 20;11(7):e0159426. doi: 10.1371/journal.pone.0159426. eCollection 2016.

5.

Overcoming the Constraints of Anti-HIV/CD89 Bispecific Antibodies That Limit Viral Inhibition.

Yu X, Duval M, Gawron M, Posner MR, Cavacini LA.

J Immunol Res. 2016;2016:9425172. doi: 10.1155/2016/9425172. Epub 2016 Jun 22.

6.

Uptake of HLA Alloantigens via CD89 and CD206 Does Not Enhance Antigen Presentation by Indirect Allorecognition.

Breman E, Ruben JM, Franken KL, Heemskerk MH, Roelen DL, Claas FH, van Kooten C.

J Immunol Res. 2016;2016:4215684. doi: 10.1155/2016/4215684. Epub 2016 Jun 20.

7.

Urinary myeloid IgA Fc alpha receptor (CD89) and transglutaminase-2 as new biomarkers for active IgA nephropathy and henoch-Schönlein purpura nephritis.

Moresco RN, Speeckaert MM, Zmonarski SC, Krajewska M, Komuda-Leszek E, Perkowska-Ptasinska A, Gesualdo L, Rocchetti MT, Delanghe SE, Vanholder R, Van Biesen W, Delanghe JR.

BBA Clin. 2016 Feb 17;5:79-84. doi: 10.1016/j.bbacli.2016.02.002. eCollection 2016 Jun.

8.

Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.

Berthelot L, Robert T, Vuiblet V, Tabary T, Braconnier A, Dramé M, Toupance O, Rieu P, Monteiro RC, Touré F.

Kidney Int. 2015 Oct;88(4):815-22. doi: 10.1038/ki.2015.158. Epub 2015 Jun 10.

PMID:
26061544
9.

Enhancement of antibody-dependent cell-mediated cytotoxicity by endowing IgG with FcαRI (CD89) binding.

Borrok MJ, Luheshi NM, Beyaz N, Davies GC, Legg JW, Wu H, Dall'Acqua WF, Tsui P.

MAbs. 2015;7(4):743-51. doi: 10.1080/19420862.2015.1047570.

10.

Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.

Papista C, Lechner S, Ben Mkaddem S, LeStang MB, Abbad L, Bex-Coudrat J, Pillebout E, Chemouny JM, Jablonski M, Flamant M, Daugas E, Vrtovsnik F, Yiangou M, Berthelot L, Monteiro RC.

Kidney Int. 2015 Aug;88(2):276-85. doi: 10.1038/ki.2015.94. Epub 2015 Mar 25.

PMID:
25807036
11.

Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironment.

Wehrli M, Cortinas-Elizondo F, Hlushchuk R, Daudel F, Villiger PM, Miescher S, Zuercher AW, Djonov V, Simon HU, von Gunten S.

J Immunol. 2014 Dec 1;193(11):5649-59. doi: 10.4049/jimmunol.1400028. Epub 2014 Oct 22.

12.

Anti-inflammatory role of the IgA Fc receptor (CD89): from autoimmunity to therapeutic perspectives.

Ben Mkaddem S, Rossato E, Heming N, Monteiro RC.

Autoimmun Rev. 2013 Apr;12(6):666-9. doi: 10.1016/j.autrev.2012.10.011. Epub 2012 Nov 29. Review.

PMID:
23201915
13.

Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.

Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.

Kidney Int. 2011 Dec;80(12):1352-63. doi: 10.1038/ki.2011.276. Epub 2011 Aug 24.

14.

The functional polymorphism 844 A>G in FcαRI (CD89) does not contribute to systemic sclerosis or rheumatoid arthritis susceptibility.

Broen JC, Coenen MJ, Rueda B, Witte T, Padyukov L, Klareskog L, Hesselstrand R, Wuttge DM, Simeon C, Ortego-Centeno N, González-Gay MA, Pros A, Hunzelman N, Riemekasten G, Kreuter A, Vonk M, Scorza R, Beretta L, Airò P, van Riel PL, Kimberly R, Martin J, Edberg J, Radstake TR.

J Rheumatol. 2011 Mar;38(3):446-9. doi: 10.3899/jrheum.100427. Epub 2010 Dec 15. Erratum in: J Rheumatol. 2011 May;38(5):968.

PMID:
21159834
15.

Immune complex formation in IgA nephropathy: CD89 a 'saint' or a 'sinner'?

Boyd JK, Barratt J.

Kidney Int. 2010 Dec;78(12):1211-3. doi: 10.1038/ki.2010.365.

16.

Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy.

Vuong MT, Hahn-Zoric M, Lundberg S, Gunnarsson I, van Kooten C, Wramner L, Seddighzadeh M, Fernström A, Hanson LÅ, Do LT, Jacobson SH, Padyukov L.

Kidney Int. 2010 Dec;78(12):1281-7. doi: 10.1038/ki.2010.314. Epub 2010 Sep 1.

17.

A recombinant bispecific single-chain fragment variable specific for HLA class II and Fc alpha RI (CD89) recruits polymorphonuclear neutrophils for efficient lysis of malignant B lymphoid cells.

Guettinger Y, Barbin K, Peipp M, Bruenke J, Dechant M, Horner H, Thierschmidt D, Valerius T, Repp R, Fey GH, Stockmeyer B.

J Immunol. 2010 Feb 1;184(3):1210-7. doi: 10.4049/jimmunol.0902033. Epub 2009 Dec 30.

18.

Inside-out regulation of Fc alpha RI (CD89) depends on PP2A.

Bakema JE, Bakker A, de Haij S, Honing H, Bracke M, Koenderman L, Vidarsson G, van de Winkel JG, Leusen JH.

J Immunol. 2008 Sep 15;181(6):4080-8.

19.

Functionality of the IgA Fc receptor (FcalphaR, CD89) is down-regulated by extensive engagement of FcepsilonRI.

Matsui T, Nunomura S, Shimokawa T, Yoshimaru T, Ra C.

Clin Immunol. 2008 Oct;129(1):155-62. doi: 10.1016/j.clim.2008.07.003. Epub 2008 Aug 12.

PMID:
18700185
20.

Nonhuman primate IgA: genetic heterogeneity and interactions with CD89.

Rogers KA, Jayashankar L, Scinicariello F, Attanasio R.

J Immunol. 2008 Apr 1;180(7):4816-24.

Supplemental Content

Support Center